Published in Endocrinology on December 01, 1995
Microfluidic device for multimodal characterization of pancreatic islets. Lab Chip (2008) 1.99
Peroxisome proliferator-activated receptor gamma activation restores islet function in diabetic mice through reduction of endoplasmic reticulum stress and maintenance of euchromatin structure. Mol Cell Biol (2009) 1.74
The Ca2+ dynamics of isolated mouse beta-cells and islets: implications for mathematical models. Biophys J (2003) 1.59
Glucose modulates [Ca2+]i oscillations in pancreatic islets via ionic and glycolytic mechanisms. Biophys J (2006) 1.35
Excitation wave propagation as a possible mechanism for signal transmission in pancreatic islets of Langerhans. Biophys J (2001) 1.23
Evidence of diminished glucose stimulation and endoplasmic reticulum function in nonoscillatory pancreatic islets. Endocrinology (2008) 1.20
Origin of slow and fast oscillations of Ca2+ in mouse pancreatic islets. J Physiol (1998) 1.17
Evidence that low-grade systemic inflammation can induce islet dysfunction as measured by impaired calcium handling. Cell Calcium (2010) 1.07
Microfluidic perfusion system for automated delivery of temporal gradients to islets of Langerhans. Anal Chem (2009) 1.04
Glucose metabolism, islet architecture, and genetic homogeneity in imprinting of [Ca2+](i) and insulin rhythms in mouse islets. PLoS One (2009) 0.98
Stimulation of exocytosis without a calcium signal. J Physiol (1999) 0.97
Episodic hormone secretion: a comparison of the basis of pulsatile secretion of insulin and GnRH. Endocrine (2014) 0.77
Phase modulation of insulin pulses enhances glucose regulation and enables inter-islet synchronization. PLoS One (2017) 0.75
Dual Detection System for Simultaneous Measurement of Intracellular Fluorescent Markers and Cellular Secretion. Anal Chem (2016) 0.75
Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab (2008) 3.96
Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. Endocr Rev (2001) 2.92
Cellular composition of the human diabetic pancreas. Diabetologia (1983) 2.71
Significance of ionic fluxes and changes in membrane potential for stimulus-secretion coupling in pancreatic B-cells. Experientia (1984) 2.43
Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Invest (1997) 2.21
Evidence that glucose can control insulin release independently from its action on ATP-sensitive K+ channels in mouse B cells. J Clin Invest (1992) 2.06
Oscillations of secretion driven by oscillations of cytoplasmic Ca2+ as evidences in single pancreatic islets. J Biol Chem (1993) 1.95
Opposite effects of tolbutamide and diazoxide on 86Rb+ fluxes and membrane potential in pancreatic B cells. Biochem Pharmacol (1982) 1.90
D-glucose inhibits potassium efflux from pancreatic islet cells. Nature (1978) 1.86
Culture duration and conditions affect the oscillations of cytoplasmic calcium concentration induced by glucose in mouse pancreatic islets. Diabetologia (1994) 1.66
Influence of membrane potential changes on cytoplasmic Ca2+ concentration in an electrically excitable cell, the insulin-secreting pancreatic B-cell. J Biol Chem (1992) 1.64
Interplay between cytoplasmic Ca2+ and the ATP/ADP ratio: a feedback control mechanism in mouse pancreatic islets. Biochem J (1998) 1.59
Mechanisms by which glucose can control insulin release independently from its action on adenosine triphosphate-sensitive K+ channels in mouse B cells. J Clin Invest (1993) 1.59
Phentolamine and yohimbine inhibit ATP-sensitive K+ channels in mouse pancreatic beta-cells. Br J Pharmacol (1990) 1.45
Mechanisms of the stimulation of insulin release by saturated fatty acids. A study of palmitate effects in mouse beta-cells. Diabetes (1994) 1.44
Tight links between adenine and guanine nucleotide pools in mouse pancreatic islets: a study with mycophenolic acid. Biochem J (1997) 1.43
The changes in adenine nucleotides measured in glucose-stimulated rodent islets occur in beta cells but not in alpha cells and are also observed in human islets. J Biol Chem (1998) 1.39
Tolbutamide stimulation and inhibition of insulin release: studies of the underlying ionic mechanisms in isolated rat islets. Diabetologia (1980) 1.34
Uptake and release of Ca2+ by the endoplasmic reticulum contribute to the oscillations of the cytosolic Ca2+ concentration triggered by Ca2+ influx in the electrically excitable pancreatic B-cell. J Biol Chem (1999) 1.33
Pronase effect on pancreatic beta cell secretion and morphology. Science (1973) 1.31
The ionic, electrical, and secretory effects of endogenous cyclic adenosine monophosphate in mouse pancreatic B cells: studies with forskolin. Endocrinology (1984) 1.23
Influence of cell number on the characteristics and synchrony of Ca2+ oscillations in clusters of mouse pancreatic islet cells. J Physiol (1999) 1.22
Possible links between glucose-induced changes in the energy state of pancreatic B cells and insulin release. Unmasking by decreasing a stable pool of adenine nucleotides in mouse islets. J Clin Invest (1995) 1.21
Concentration dependence and time course of the effects of glucose on adenine and guanine nucleotides in mouse pancreatic islets. J Biol Chem (1996) 1.20
Effects of amino acids on membrane potential and 86Rb+ fluxes in pancreatic beta-cells. Am J Physiol (1981) 1.19
Stable and diffusible pools of nucleotides in pancreatic islet cells. Endocrinology (1996) 1.17
Cyclic variations of glucose-induced electrical activity in pancreatic B cells. Pflugers Arch (1982) 1.17
Cobalt inhibition of insulin secretion and calcium uptake by isolated rat islets. Am J Physiol (1975) 1.17
Effects of putative activators of K+ channels in mouse pancreatic beta-cells. Br J Pharmacol (1989) 1.17
Tetraethylammonium potentiation of insulin release and inhibition of rubidium efflux in pancreatic islets. Biochem Biophys Res Commun (1977) 1.17
Diazoxide and D600 inhibition of insulin release. Distinct mechanisms explain the specificity for different stimuli. Diabetes (1982) 1.15
High glucose stimulates early response gene c-Myc expression in rat pancreatic beta cells. J Biol Chem (2001) 1.11
High incidence of hypoglycaemia in African patients treated with intravenous quinine for severe malaria. Br Med J (Clin Res Ed) (1987) 1.11
Imidazoline antagonists of alpha 2-adrenoceptors increase insulin release in vitro by inhibiting ATP-sensitive K+ channels in pancreatic beta-cells. Br J Pharmacol (1992) 1.11
The ionic, electrical, and secretory effects of protein kinase C activation in mouse pancreatic B-cells: studies with a phorbol ester. Endocrinology (1987) 1.10
Emptying of intracellular Ca2+ stores stimulates Ca2+ entry in mouse pancreatic beta-cells by both direct and indirect mechanisms. J Physiol (1997) 1.10
Quinine-induced modifications of insulin release and glucose metabolism by isolated pancreatic islets. FEBS Lett (1975) 1.10
Measurements of cytoplasmic Ca2+ in islet cell clusters show that glucose rapidly recruits beta-cells and gradually increases the individual cell response. Diabetes (2001) 1.10
Metabolic control of potassium permeability in pancreatic islet cells. Biochem J (1980) 1.07
Pulsatility of insulin and glucagon release: physiological significance and pharmacological implications. Diabetologia (1987) 1.07
The influence of gamma-aminobutyric acid on hormone release by the mouse and rat endocrine pancreas. Endocrinology (1991) 1.06
Potassium dependence of the membrane potential of pancreatic B-cells. FEBS Lett (1978) 1.05
Glucagon immunoassay using polyethylene glycol to precipitate antibody-bound hormone. Diabetologia (1974) 1.04
Cell populations in the endocrine pancreas of human neonates and infants. Diabetologia (1981) 1.04
Diet- and diabetes-induced changes of ob gene expression in rat adipose tissue. FEBS Lett (1995) 1.03
Disorganization of cytoplasmic Ca(2+) oscillations and pulsatile insulin secretion in islets from ob/ obmice. Diabetologia (2002) 1.03
Phlorizin treatment of diabetic rats partially reverses the abnormal expression of genes involved in hepatic glucose metabolism. Diabetologia (1993) 1.02
Quinine and the stimulus-secretion coupling in pancreatic beta-cells: glucose-like effects on potassium permeability and insulin release. Endocrinology (1982) 1.02
Two sites of glucose control of insulin release with distinct dependence on the energy state in pancreatic B-cells. Biochem J (1994) 1.01
Temporal and quantitative correlations between insulin secretion and stably elevated or oscillatory cytoplasmic Ca2+ in mouse pancreatic beta-cells. Diabetes (1998) 1.01
The islet in type 2 diabetes: back to center stage. Diabetes (2001) 1.01
Oscillations of insulin secretion can be triggered by imposed oscillations of cytoplasmic Ca2+ or metabolism in normal mouse islets. Diabetes (1999) 1.00
The K+-ATP channel-independent pathway of regulation of insulin secretion by glucose: in search of the underlying mechanism. Diabetes (1998) 0.99
Mechanism of the stimulation of insulin release in vitro by HB 699, a benzoic acid derivative similar to the non-sulphonylurea moiety of glibenclamide. Diabetologia (1985) 0.98
Effects of trifluoperazine and pimozide on stimulus-secretion coupling in pancreatic B-cells. Suggestion for a role of calmodulin? Biochem J (1981) 0.98
The role of protein kinase-C in signal transduction through vasopressin and acetylcholine receptors in pancreatic B-cells from normal mouse. Endocrinology (1994) 0.97
A single mechanism for the stimulation of insulin release and 86Rb+ efflux from rat islets by cationic amino acids. Biochem J (1982) 0.97
Altered cAMP and Ca2+ signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype. Diabetes (1999) 0.96
Forskolin, an activator of adenylate cyclase, increases CA2+-dependent electrical activity induced by glucose in mouse pancreatic B cells. Endocrinology (1983) 0.96
Dibutyryl cyclic AMP triggers Ca2+ influx and Ca2+-dependent electrical activity in pancreatic B cells. Biochem Biophys Res Commun (1983) 0.95
Haeme-oxygenase 1 expression in rat pancreatic beta cells is stimulated by supraphysiological glucose concentrations and by cyclic AMP. Diabetologia (2003) 0.95
Bicarbonate modulation of glucose-9nduced biphasic insulin release by rat islets. Am J Physiol (1976) 0.95
The potassium permeability of pancreatic islet cells: mechanisms of control and influence on insulin release. Horm Metab Res Suppl (1980) 0.94
9-Aminoacridine- and tetraethylammonium-induced reduction of the potassium permeability in pancreatic B-cells. Effects on insulin release and electrical properties. Biochim Biophys Acta (1979) 0.94
Glucose-, calcium- and concentration-dependence of acetylcholine stimulation of insulin release and ionic fluxes in mouse islets. Biochem J (1988) 0.94
Highly potent and stereoselective effects of the benzoic acid derivative AZ-DF 265 on pancreatic beta-cells. Br J Pharmacol (1988) 0.93
Increased glucose sensitivity of both triggering and amplifying pathways of insulin secretion in rat islets cultured for 1 wk in high glucose. Am J Physiol Endocrinol Metab (2004) 0.93
Distinct effects of acetylcholine and glucose on 45calcium and 86rubidium efflux from mouse pancreatic islets. FEBS Lett (1984) 0.93
Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa/fa rats. Endocrinology (1989) 0.92
Mechanisms of the stimulation of insulin release by arginine-vasopressin in normal mouse islets. J Biol Chem (1990) 0.92
Clonidine inhibits ATP-sensitive K+ channels in mouse pancreatic beta-cells. Br J Pharmacol (1991) 0.92
The interplay between cyclic AMP and ions in the stimulus-secretion coupling in pancreatic B-cells. Arch Int Physiol Biochim (1985) 0.91
Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells. Endocrinology (1999) 0.90
Modulation of the effect of acetylcholine on insulin release by the membrane potential of B cells. Endocrinology (1987) 0.90
The role of metabolism, cytoplasmic Ca2+, and pH-regulating exchangers in glucose-induced rise of cytoplasmic pH in normal mouse pancreatic islets. J Biol Chem (1995) 0.90
Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeogenic enzymes in diabetic rats. Diabetologia (1996) 0.90
Pharmacological stimulation and inhibition of insulin secretion in mouse islets lacking ATP-sensitive K+ channels. Br J Pharmacol (2010) 0.90
High glucose and hydrogen peroxide increase c-Myc and haeme-oxygenase 1 mRNA levels in rat pancreatic islets without activating NFkappaB. Diabetologia (2005) 0.89
G protein-dependent inhibition of L-type Ca2+ currents by acetylcholine in mouse pancreatic B-cells. J Physiol (1997) 0.89
Relative importance of extracellular and intracellular calcium for the two phases of glucose-stimulated insulin release: studies with theophylline. Endocrinology (1978) 0.89
Cationic environment and dynamics of insulin secretion. III. Effect of the absence of potassium. Diabetologia (1974) 0.89
Sulphonylureas do not increase insulin secretion by a mechanism other than a rise in cytoplasmic Ca2+ in pancreatic B-cells. Eur J Pharmacol (1996) 0.89
The role of vanadium in the management of diabetes. Trends Pharmacol Sci (1995) 0.88
Membrane and intracellular effects of adenosine in mouse pancreatic beta-cells. Am J Physiol (1989) 0.88
The permissive effect of glucose, tolbutamide and high K+ on arginine stimulation of insulin release in isolated mouse islets. Diabetologia (1987) 0.88
The non-sulfonylurea moiety of gliquidone mimics the effects of the parent molecule on pancreatic B-cells. Eur J Pharmacol (1986) 0.88
Muscarinic stimulation exerts both stimulatory and inhibitory effects on the concentration of cytoplasmic Ca2+ in the electrically excitable pancreatic B-cell. Biochem J (1995) 0.88
Cationic environment and dynamics of insulin secretion. II. Effect of a high concentration of potassium. Diabetes (1974) 0.87
Multiple effects and stimulation of insulin secretion by the tyrosine kinase inhibitor genistein in normal mouse islets. Br J Pharmacol (1995) 0.87
Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats. Endocrinology (1988) 0.87
B cell adrenoceptors and sulphonylurea-induced insulin release in mouse islets. Diabetologia (1990) 0.87
Tolbutamide and diazoxide influence insulin secretion by changing the concentration but not the action of cytoplasmic Ca2+ in beta-cells. Diabetes (1998) 0.87
Cyclic adenosine monophosphate differently affects the response of mouse pancreatic beta-cells to various amino acids. J Physiol (1986) 0.87
Activation of muscarinic receptors increases the concentration of free Na+ in mouse pancreatic B-cells. FEBS Lett (1993) 0.87
Subplasmalemmal Ca(2+) measurements in mouse pancreatic beta cells support the existence of an amplifying effect of glucose on insulin secretion. Diabetologia (2010) 0.87
The electrogenic sodium-potassium pump of mouse pancreatic B-cells. J Physiol (1982) 0.87
Cationic environment and dynamics of insulin secretion. I. Effect of low concentrations of sodium. Endocrinology (1974) 0.86
Inhibition of protein synthesis sequentially impairs distinct steps of stimulus-secretion coupling in pancreatic beta cells. Endocrinology (2001) 0.86
Developmental and nutritional changes of ob and PPAR gamma 2 gene expression in rat white adipose tissue. Biochem J (1997) 0.85
Abundance of somatostatin cells in the human neonatal pancreas. Diabetologia (1980) 0.85